Lyme disease diagnosis and treatment: Lessons from the AIDS epidemic

Minerva Medica

Volumn 101, Issue 6, 2010, Pages 419-425

  Stricker, R B ^a   Johnson, L ^a  

^a International Lyme and Associated Diseases Society   (United States)

Author keywords

Acquired immunodeficiency syndrome; Borrelia burgdorferi; HIV; Lyme disease

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CEFUROXIME; DOXYCYCLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LYME DISEASE; MONOTHERAPY; REVIEW; SHORT COURSE THERAPY; TREATMENT FAILURE; WESTERN BLOTTING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; BITES AND STINGS; BORRELIA BURGDORFERI; DRUG THERAPY, COMBINATION; EPIDEMICS; HIV INFECTIONS; HIV-1; HUMANS; LYME DISEASE; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TICKS; UNITED STATES;

EID: 79952652917     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Stricker RB, Lautin A, Burrascano JJ. Lyme disease: point/counterpoint. Expert Rev Anti-Infect Ther 2005;3:155-65.
2. Harvey WT, Salvato P. "Lyme disease": ancient engine of an unrecognized borreliosis pandemic? Med Hypotheses 2003;60:742-59.
3. Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti-Infect Ther 2004;2(1 Suppl):S1-13.
4. Johnson L, Stricker RB. Treatment of Lyme disease: a medicolegal assessment. Expert Rev Anti-Infect Ther 2004;2:533-57. (Pubitemid 39162364)
5. Stricker RB, Johnson L. Lyme disease: a turning point. Expert Rev Anti-Infect Ther 2007;5:759-62. (Pubitemid 47610939)
6. Stricker RB, Johnson L. Lyme disease debate: facts or fiction. BMJ Rapid Response [cited 2010 October 18]. Available at: http://www.bmj.com/content/335/ 7628/1008.1.full/reply-bmj-e1-194233
7. CDC. Reported cases of Lyme disease by year, United States, 1994-2008. [cited 2010 October 18]. Available at: http://www.cdc.gov/ncidod/dvbid/Lyme/ld- Up-ClimbLymeDis.htm.
8. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-6.
9. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS et al. The clinical assessment, treatment, and prevention of Lyme disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;41:1089-134. (Pubitemid 44637131)
10. Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP et al. Practice parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;69:91-102. (Pubitemid 47025211)
11. Sigal LH, Hassett AL. Contributions of societal and geographical environments to "chronic Lyme disease": the psychopathogenesis and aporology of a new "medically unexplained symptoms" syndrome. Environ Health Perspect 2002;110(Suppl 4):607-11.
12. Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007;357:1422-30.
13. Connecticut Attorney General's Office. Attorney General's investigation reveals flawed Lyme disease guideline process, IDSA agrees to reassess guidelines, install independent arbiter. [cited 2010 October 18]. Available at: http://www.ct.gov/ag/cwp/view.asp?a=2795&q=414284
14. Stricker RB, Johnson L. The Infectious Diseases Society of America Lyme guidelines: poster child for guidelines reform. South Med J 2009;102:565-6.
15. Johnson L, Stricker RB. The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about development of clinical practice guidelines. Philos Ethics Humanit Med 2010;5:9.
16. Appelbaum JS, Elion R, Henry K, Newman MD, Saag MS, Sax PE. Roundtable. Who should be providing HIV care? AIDS Clin Care 2006;18:21-4.
17. Schmitz JL, Powell CS, Folds JD. Comparison of seven commercial kits for detection of antibodies to Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 1993;12:419-24. (Pubitemid 23214065)
18. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-27.
19. Ledue TB, Collins MF, Craig WY. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol 1996;34:2343-50. (Pubitemid 26307769)
20. Tilton RC, Sand MN, Manak M.. The Western immunoblot for Lyme disease: determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels. Clin Infect Dis 1997;25(Suppl 1):S31-4.
21. Trevejo RT, Krause PJ, Sikand VK, Schriefer ME, Ryan R, Lepore T et al. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J Infect Dis 1999;179:931-8. (Pubitemid 29159339)
22. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003;187:1187-99.
23. Binnicker MJ, Jespersen DJ, Hairing JA, Rollins LO, Bryant SC, Beito EM. Evaluation of two commercial systems for automated processing, reading, and interpretation of Lyme borreliosis Western blots. J Clin Microbiol 2008;46:2216-21.
24. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for lyme disease. Clin Infect Dis 2008;47:188-95. (Pubitemid 351920619)
25. Stricker RB, Johnson L. Lyme wars: let's tackle the testing. BMJ 2007;335:1008.
26. Santino I, Berlutti F, Pantanella F, Sessa R, del Piano M. Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis. FEMS Microbiol Lett 2008;283:30-5. (Pubitemid 351595008)
27. National Institutes of Health. The impact of routine HTLV-III antibody testing on public health. Natl Inst Health Consens Dev Conf Consens Statement 1986;6:1-9. [cited 2010 October 18]. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/3537748
28. Xu Y, Bruno JF, Luft BJ. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays. Microb Pathog 2008;45:403-7. (Pubitemid 50336682)
29. Montagnier L, Aïssa J, Ferris S, Montagnier JL, Lavallée C. Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdiscip Sci 2009;1:81-90.
30. Montagnier L, Aïssa J, Lavallée C, Mbamy M, Varon J, Chenal H. Electromagnetic detection of HIV DNA in the blood of AIDS patients treated by antiretroviral therapy. Interdiscip Sci 2009;1:245-53.
31. Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett 2001;76:43-8. (Pubitemid 32166910)
32. Stricker RB, Burrascano J, Winger EE. Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann Agric Environ Med 2002;9:111-3. (Pubitemid 34686027)
33. Shoemaker RC, Giclas PC, Crowder C, House D, Glovsky MM. Complement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United States. Int Arch Allergy Immunol 2008;146:255-61. (Pubitemid 351832469)
34. Stricker RB, Savely VR, Motanya NC, Giclas PC. Complement split products C3a and C4a in chronic Lyme disease. Scand J Immunol 2009;69:64-9.
35. Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N et al. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun 2010;24:1018-24.
36. Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L. Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Minerva Med 2010;101:1-7.
37. Freeman HJ. Tropheryma whipplei infection. World J Gastroenterol 2009;15:2078-80.
38. Liu YH, Wang XG, Gao JS, Qingyao Y, Horton J. Continuous albendazole therapy in alveolar echinococcosis: long-term follow-up observation of 20 cases. Trans R Soc Trop Med Hyg 2009;103:768-78.
39. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A et al.; International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010;304:321-33.
40. Stricker RB. Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007;45:149-57. (Pubitemid 47041004)
41. Gasser R, Wendelin I, Reisinger E, Bergloff J, Feigl B, Schafhalter I et al. Roxithromycin in the treatment of Lyme disease-update and perspectives. Infection 1995;23(Suppl 1):S39-43.
42. Donta ST. Macrolide therapy of chronic Lyme disease. Med Sci Monit 2003;9:PI136-42.
43. Stricker RB, Johnson L. Chronic Lyme disease and the "Axis of Evil". Future Microbiol 2008;3:621-4.
44. Cameron D. Obstacles to trials of chronic Lyme disease in actual practice. Minerva Med 2009;100:435-6.
45. Cameron DJ. Proof that chronic Lyme disease exists. Interdiscip Perspect Infect Dis 2010;2010:876450.